Michael Higgins

Michael Higgins

Analyst-Equity en Ladenburg Thalmann & Co., Inc. (Broker) .

Finance
Consumer Services
Health Technology

Perfil

Mr. Michael Higgins is a Managing Director & Senior Biopharmaceuticals Equity Research at Ladenburg Thalmann & Co., Inc. He has over 15 years of experience as a biopharmaceuticals analyst.
His current focus is on therapeutic companies, including pain/addiction, anti-infectives, neurological and drug delivery.
Prior to joining Ladenburg Thalmann, he was a Managing Director, Senior Research Analyst at ROTH Capital Partners as well as Rodman & Renshaw Capital LLC.
Mr. Higgins began his career in equity research at Dafna Capital in Beverly Hills, CA where he focused on drug launches of biopharmaceutical companies, which followed ten years in pharmaceutical marketing at Procter & Gamble Pharmaceuticals.
Mr. Higgins earned his Bachelor of Science in Finance from the University of Wisconsin-Stevens Point and his MBA with a focus on Finance and Investment Analysis from Marquette University.

Cargos activos de Michael Higgins

EmpresasCargoInicio
Analyst-Equity 01/11/2017
Todos los cargos activos de Michael Higgins

Antiguos cargos conocidos de Michael Higgins.

EmpresasCargoFin
Analyst-Equity 01/11/2017
Corporate Officer/Principal 31/03/2015
Director Ejecutivo 01/03/2015
Analyst-Equity -
Director de Investigación - Acciones -
Ver el detalle de la experiencia de Michael Higgins.

Formación de Michael Higgins.

Marquette University Masters Business Admin
University of Wisconsin Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Michael Higgins.

Relaciones

99

Relaciones de 1er grado

13

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas11

Finance

Finance

Finance

Finance

Finance

Finance

Finance

Health Technology

Finance

Finance

Finance

Ver las conexiones de la empresa
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA